132 related articles for article (PubMed ID: 8106868)
1. HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients.
Morris DJ; Martin S; Dyer PA; Hunt L; Mallick NP; Johnson RW
J Med Virol; 1993 Dec; 41(4):324-7. PubMed ID: 8106868
[TBL] [Abstract][Full Text] [Related]
2. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
3. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease.
Blancho G; Josien R; Douillard D; Bignon JD; Cesbron A; Soulillou JP
Transplantation; 1992 Nov; 54(5):871-4. PubMed ID: 1332224
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
5. [Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation].
Pouteil-Noble C; Bétuel H; Raffaele P; Megri K; Louvier C; Lefrançois N; Bosshard S; Dubernard JM; Aymard M; Touraine JL
Presse Med; 1991 Nov; 20(40):2022-4. PubMed ID: 1662376
[TBL] [Abstract][Full Text] [Related]
6. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function.
McKenna RM; Lee KR; Gough JC; Jeffery JR; Grimm PC; Rush DN; Nickerson P
Transplantation; 1998 Jul; 66(1):38-43. PubMed ID: 9679819
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients.
Pouteil-Noble C; Ecochard R; Landrivon G; Donia-Maged A; Tardy JC; Bosshard S; Colon S; Betuel H; Aymard M; Touraine JL
Transplantation; 1993 Apr; 55(4):851-7. PubMed ID: 8386406
[TBL] [Abstract][Full Text] [Related]
8. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection and graft rejection in renal transplantation.
Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
[TBL] [Abstract][Full Text] [Related]
11. Evidence that matching for HLA antigens significantly increases transplant survival in 1001 renal transplants performed in the northwest region of England.
Dyer PA; Johnson RW; Martin S; Bakran A; Gokal R; Harris R; Mallick NP; Manos J; Orr WM; Pearson RC
Transplantation; 1989 Jul; 48(1):131-5. PubMed ID: 2665219
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching.
Schnitzler MA; Lowell JA; Hmiel SP; Hardinger KL; Liapis H; Ceriotti CS; Brennan DC
J Am Soc Nephrol; 2003 Mar; 14(3):780-5. PubMed ID: 12595516
[TBL] [Abstract][Full Text] [Related]
13. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
[TBL] [Abstract][Full Text] [Related]
14. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy.
Kraat YJ; Christiaans MH; Nieman FH; van den Berg-Loonen PM; van Hooff JP; Bruggeman CA
Transpl Int; 1994 Aug; 7(5):362-7. PubMed ID: 7993574
[TBL] [Abstract][Full Text] [Related]
16. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
17. Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.
Yacoub R; Nadkarni GN; Cravedi P; He JC; Delaney VB; Kent R; Chauhan KN; Coca SG; Florman SS; Heeger PS; Murphy B; Menon MC
Kidney Int; 2018 Feb; 93(2):482-490. PubMed ID: 28965746
[TBL] [Abstract][Full Text] [Related]
18. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients.
Cicciarelli J; Terasaki PI; Mickey MR
Transplantation; 1987 May; 43(5):636-40. PubMed ID: 3554654
[TBL] [Abstract][Full Text] [Related]
19. The effect of mismatching for HLA-DR in recipients of renal allografts sharing one HLA-ABC haplotype with related donors.
Sutherland DE; Morrow CE; Kaufman D; Fryd DS; Najarian JS; Burke M; Noreen H; Segall M; Bach FH
Transplantation; 1983 Dec; 36(6):643-7. PubMed ID: 6362140
[TBL] [Abstract][Full Text] [Related]
20. Association of rheumatoid factors in renal transplant recipients with cytomegalovirus infection and not with rejection.
Baldwin WM; Westedt ML; van Gemert GW; Henny FC; Paul LC; Daha MR; van Es LA
Transplantation; 1987 May; 43(5):658-62. PubMed ID: 3033854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
